Didactics-FIGO Cervical Cancer Staging

Video Transcription

Video Summary

In this video, Professor An discusses the revised staging system for cervical cancer. The aim of the revision was to maintain global unanimity, incorporate new technology, and improve utility and applicability. The changes in staging mainly affected stage one and stage three of the disease. Imaging and pathology assessment can now be used in staging to determine tumor size, invasion, lymph node status, and overall extent of the disease. The choice of imaging technique is flexible and can be based on local resources. However, it is important to consider the limitations and potential variations in outcomes with different imaging techniques. Professor An also mentions the possibility of incorporating Sentinel-Node assessment in research protocols for early stage cancer. Overall, the revised staging system allows for more flexibility and the use of available clinical resources.

Asset Subtitle

Professor Hextan Ngan
October 2021

Keywords

revised staging system

cervical cancer

imaging

pathology assessment

Sentinel-Node assessment